Anti-tumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis
✍ Scribed by Norio Komai; Yoshitaka Morita; Takeo Sakuta; Atsunori Kuwabara; Naoki Kashihara
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 280 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1439-7595
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective Cardiovascular disease is the major cause of excessive mortality in rheumatoid arthritis (RA). Atherosclerosis and RA share similar inflammatory mechanisms that include involvement of tumor necrosis factor α (TNFα). Anti‐TNFα antibody improved endothelial function in RA pa
## Abstract ## Objective To assess the association between the initiation of anti–tumor necrosis factor α (anti‐TNFα) therapy and the risk of serious bacterial infections in routine care. ## Methods This was a cohort study of patients with rheumatoid arthritis (RA) in whom specific disease‐modif